Press Releases

GlobeNewswire, Inc.

WILMETTE, Ill., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today...

GlobeNewswire, Inc.

BOSTON, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Flywire Corporation (Nasdaq: FLYW), a global payments enablement and software company, today announced expanded support for open banking payments in the U.S. and Canada with Trustly, allowing payers to...

EIN Presswire

Pelicargo Announces Strategic Investment from Mitsubishi Logistics CVC CAMBRIDGE, MA, UNITED STATES, August 12, 2026 /⁨EINPresswire.com⁩/ -- Pelicargo, a digital air cargo quoting and booking technology, today announced that it has received a...

EIN Presswire

CYPRUS, CYPRUS, August 12, 2026 /⁨EINPresswire.com⁩/ -- Mark your calendars for Wiki Finance Expo Cyprus 2026, taking place on November 6, 2026 at the prestigious Parklane, a Luxury Collection Resort & Spa. As one of Europe’s most influential...

EIN Presswire

İSTANBUL, TURKEY, August 12, 2026 /⁨EINPresswire.com⁩/ -- Inaugural GITEX Ai Türkiye 2026 unites global tech ecosystem at Istanbul Expo Centre on 9–10 September as the world’s largest tech and AI event network spotlights Eurasia’s fast-rising...

GlobeNewswire, Inc.

JUPITER, Fla., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered,...

GlobeNewswire, Inc.

BALLERUP, Denmark, Aug. 12, 2026 (GLOBE NEWSWIRE) -- LiqTech International, Inc. (Nasdaq: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results...

GlobeNewswire, Inc.

Ramat Gan, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (NASDAQ/TASE: ODYS), a leader in AI-powered visual sensing and predictive maintenance (PdM) solutions for the defense and industrial markets, today announced that management...

GlobeNewswire, Inc.

Completed pre-IND meeting with the FDA for CNTY-813, an iPSC-derived islet replacement therapy with functional cure potential in type 1 diabetes (T1D); IND submission on track for 4Q 2026 CNTY-813 preclinical data from oral presentation at ADA...

GlobeNewswire, Inc.

Completed enrollment of MIST global Phase 2b trial of AP01 with 398 patients; topline data expected in the second half of 2027 Two abstracts accepted for presentation at the European Respiratory Society (ERS) Congress, including data modeling AP01...

GlobeNewswire, Inc.

Initiated global PERFORMA Phase 3 trial in MASH Reported positive topline data from RECLAIM Phase 2 trial in AUD Completed patient enrollment in RESTORE Phase 2 trial in ALD $519 million in cash, cash equivalents and investments as of June 30,...

GlobeNewswire, Inc.

DUBLIN, Ireland, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (Nasdaq: HTOO) ("Fusion Fuel" or the "Company"), a leading provider of full-service energy engineering, advisory, and utility solutions, today announced that its wholly-owned...

GlobeNewswire, Inc.

Delivered record Q2 Contribution ex-TAC and programmatic revenue, highlighted by all-time record quarterly CTV revenue; raises full-year 2026 Contribution ex-TAC and programmatic revenue guidance for the third time this year Advanced nexAI through...

EIN Presswire

MADRID, SPAIN, August 12, 2026 /⁨EINPresswire.com⁩/ -- OpenNebula Systems, the leading provider of Sovereign Cloud and AI Factory management software, today announced a collaboration with Nokia to strengthen Europe's digital sovereignty by...

GlobeNewswire, Inc.

Randomized Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) ongoing, with results expected in 1H 2027; potential registration trial expected in 2027 once recommended dose regimen has been established Data reported at AACR from...

GlobeNewswire, Inc.

FDA Accepted D-PLEX₁₀₀ NDA with Priority Review; PDUFA Goal Date of November 28, 2026, Approximately One Quarter Ahead of Previously Communicated Guidance Exclusive U.S. and Canada Commercialization Partnership with Azurity Pharmaceuticals; $30...

GlobeNewswire, Inc.

NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD; HKEX: 0800), a global leader in autonomous driving technology, today announced its unaudited financial results for the second quarter and first half...

GlobeNewswire, Inc.

Over 50% of commercially insured lives in the U.S., representing a recent and significant increase, now have coverage for CARDAMYST® (etripamil) nasal spray Phase 3 registrational trial of etripamil for atrial fibrillation with rapid ventricular...

GlobeNewswire, Inc.

Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026 Two candidates nominated for development in Acumen’s Enhanced Brain Delivery™ (EBD™)...

GlobeNewswire, Inc.

Topline data from CHAPTER-3, a pivotal Phase 3 study of deucrictibant XR for the prophylaxis of HAE attacks, expected in 3Q2026 Deucrictibant IR NDA under review by the FDA with PDUFA date of April 23, 2027; MAA validated by the EMA in July 2026...